Discover open access scientific publications

Search, annotate, share and cite publications

Publications by James Hao

Efficacy of Lanadelumab in Hereditary Angioedema Patients Switching From C1 Inhibitor Long-Term Prophylaxis: Interim Results From the HELP Open-Label Extension Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Lanadelumab and Cardiovascular Risk: Findings From the Phase 3 HELP Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Related publications

Long-Term Prophylaxis With Recombinant Human C1 Inhibitor in Patients With Hereditary Angioedema: Is Intramuscular Administration an Option?

Journal of Allergy and Clinical Immunology
AllergyImmunology
2018English

Effect of Lanadelumab on Coagulation Parameters in Patients With Hereditary Angioedema: Findings From the Phase 3 HELP Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Long-Term Safety of Subcutaneous C1-Inhibitor in the Prophylactic Treatment of Hereditary Angioedema

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Safety, Efficacy, and Pharmacokinetics of Intravenous C1 Esterase Inhibitor (Human) Prophylaxis in Children With Hereditary Angioedema (HAE)

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

A Randomized Trial of Human C1 Inhibitor Prophylaxis in Children With Hereditary Angioedema

Pediatric Allergy and Immunology
ImmunologyChild HealthAllergyPediatricsPerinatology
2019English

Successful C1 Inhibitor Short-Term Prophylaxis During Redo Mitral Valve Replacement in a Patient With Hereditary Angioedema

Journal of Cardiothoracic Surgery
CardiologyCardiovascular MedicineMedicinePulmonaryRespiratory MedicineSurgery
2010English

Long-Term Efficacy and Safety of RPC4046, an Anti-Interleukin-13 Monoclonal Antibody, in Patients With Eosinophilic Esophagitis: Results From the Open-Label Extension of the HEROES Study

Journal of Allergy and Clinical Immunology
AllergyImmunology
2019English

Tofacitinib, an Oral Janus Kinase Inhibitor, for the Treatment of Chronic Plaque Psoriasis: Long-Term Efficacy and Safety Results From 2 Randomized Phase-Iii Studies and 1 Open-Label Long-Term Extension Study

Journal of the American Academy of Dermatology
Dermatology
2016English

Ziprasidone in Adolescents With Schizophrenia: Results From a Placebo-Controlled Efficacy and Long-Term Open-Extension Study

Journal of Child and Adolescent Psychopharmacology
Mental HealthChild HealthPharmacologyPerinatologyPsychiatryPediatrics
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy